Authors
Latest:
New Bespoke Gene Therapy Consortium Is Welcome DevelopmentFor biopharma innovation to succeed and accelerate, companies must stop duplicating their efforts and share valuable information.
Latest:
Why Pharma Should Develop a Core Digital OfferingHow can pharma create solutions that are effective, can provide long-term value, and will actually be adopted by HCPs and patients?
Latest:
Rx Power Struggle: How Pharma can Flip the PBM ScriptThe industry holds the key to true change to the drug access landscape.
Latest:
Orphan Drugs: From Niche to MainstreamLarger pipeline and increased support from regulatory authorities are setting up the orphan drug market for long-term success.
Latest:
Elevate and De-Risk Your Drug Portfolio Strategy With AIWebinar Date/Time: Wed, Aug 28, 2024 11:00 AM EDT
Latest:
Making the Grade: Registries as Sources of Regulatory-Grade RWEDr Peter Wahl, MLA, MS, Global Head of Scientific Affairs at CorEvitas, part of the PPD clinical research business of Thermo Fisher Scientific, covers key considerations for choosing registries.
Latest:
Survey: Pandemic impact on consumer trust in biopharmaThe biopharma industry launched COVID vaccines and treatments in record time. How did this impact consumer trust? We asked, and compared survey results with 2017 data.
Latest:
Personalizing Pharma: Overcoming Challenges to Drive Digital Customer EngagementAs HCPs continue to face time constraints and information overload, delivering relevant and personalized content becomes increasingly critical.
Latest:
A Risk-Reward Reset: Getting Serious About Social MediaAs the digital medium poses new threats to brand equity and public safety for pharma, what can drugmakers do to better balance its essential communications benefits with the risks?
Latest:
The Real Cost of State Drug Importation Programs? Patient SafetyImporting drugs from Canada may increase the risk of US citizens being exposed to unsafe medicines.
Latest:
Maximizing China Access for Innovative TherapiesTo maximize the potential of innovative therapies in the Chinese market, it’s important to have a holistic view of the full range of options and levers, prioritize and sequence the ones with the highest impacts, and develop an integrated strategy tailored to address the country’s unmet needs.
Latest:
How to Make Your Meetings with HCPs More Insightful and SuccessfulEncounters with healthcare providers (HCPs) requires diligent preparation. Beyond understanding the value of the therapies you're offering, all touchpoints and conversations are of the highest importance - through sharing research, new ideas, and how you can support HCPs, you gain valuable, relevant insights that inform your relationship with HCPs and help them blossom.
Latest:
Evolution of Prostate Cancer Treatment Gathers SpeedAmy Butcher evaluates the current treatment options for prostate cancer and the looks to the future as clinical outcomes evolve.
Latest:
Creating Data-driven, Personalized User ExperiencesIn this video Akeel Williams, VP of Strategy and Operations, Manufacturer Solutions, explains how GoodRx uses data to continuously improve its platform for patients and providers.
Latest:
Successful Digital Transformation Depends on Quality Customer DataCompanies recognize that their success with digital starts with accurate customer data, but many struggle to manage the overwhelming volume of different data types from hundreds of sources.
Latest:
Five Steps for Automating the Pharmacovigilance ProcessHere’s how pharma businesses can speed the handling of adverse events, reduce costs, improve patient safety and spur growth through pharmacovigilance automation.
Latest:
Q&A With Daniel Lofaso, CEO of Digital ElevatorLofaso discusses strategies that biotech companies can take once its time to make the big push.
Latest:
The Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business ModelsThe era of big pharma as product-first companies must end, as services become the larger priority.
Latest:
Examining Data Breaches in Pharma Companies During COVID-19Pharma companies are struggling to maintain a high level of cybersecurity amidst the pandemic.
Latest:
How Leaders Can Empower Their People to be Their BestIf you wish for your team to be diligent, innovative, and collaborative, you must first exhibit these traits yourself
Latest:
Embracing the Renaissance of Small Molecule Drug DiscoveryPharma companies may benefit from meeting challenges and embracing small molecule drug discovery.
Latest:
Four Key Strategies for Optimizing Your Medical Congress StrategyConferences, congresses, and the digital discussions kicked off by those events create a halo effect that amplifies scientific information more so than other scientific activities.
Latest:
Operating Models for Successful DOL EngagementHow life sciences companies can design an effective operating model for DOL engagements.
Latest:
Accelerating Rare Disease Drug Development with NLP: Three Use CasesUtilizing natural language processing technologies to improve search capabilities and advance the development of therapies.
Latest:
Bridging the Divide: Medical's Omnichannel MomentumHow pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.
